Curepreventperform
ActiveSummary
Curepreventperform has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €160,394 and a net result of €58,372. Its solvency ranks better than 80% of 20,358 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
10-08
NBB filing
Annual accounts filed
financial year 2025 · micro format · 10 days late
2025
31-12
Financial
Liquidity more than doubledcurrent ratio 5.36
Current ratio from 2.37 to 5.36.
31-12
Financial
Equity above €150,000equity €160,394 ▲57.2%
A profit in every financial year since 2024 builds equity to €160,394.
24-06
NBB filing
Annual accounts filed
financial year 2024 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.